Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects

The aim of this study was to apply the reference-scaled average bioequivalence (RSABE) approach to evaluate the bioequivalence of 2 formulations of agomelatine, and to investigate the pharmacokinetic properties of agomelatine in Chinese healthy male subjects. This was performed in a single-dose, ran...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Fang Tang, Rui Zhou, Zeneng Cheng, Guoping Yang, Aiqiao Chen, Zhi Liu, Hongyi Tan, Shuang Yang, Sanwang Li, Lingli Mu, Peng Yu
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2016-01-01
Saila:Acta Pharmaceutica Sinica B
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2211383515001446